Executive Moves
Glaxo’s Former Head of Biopharmaceutical Research Joins F-Star
|
F-Star, a clinical-stage developer of antibodies to treat cancer, named former GlaxoSmithKline (GSK) executive Neil Brewis as its chief scientific officer.
Growth Capitalist (https://growthcapitalist.com/category/premium-articles/executive-moves/page/5/)
Emerging growth capital market executive comings and goings.
F-Star, a clinical-stage developer of antibodies to treat cancer, named former GlaxoSmithKline (GSK) executive Neil Brewis as its chief scientific officer.
Eric Heinz, a former marketing manager with medical device companies including IMRIS, Zimmer Inc. and Intuitive Surgical Inc., joined boutique investment bank Emergent Financial Group as a managing director.
Adam Steinhauer has joined Growth Capital Investor as Senior Editor, where he will lead the publication's news reporting and editing on emerging growth company finance.
Middle market investment firm Victory Park Capital hired former Citigroup banker Karrie Truglia as a vice president as part of an expansion that also added six associates and operations staff members.